Ranmore Fund Management’s Dentsply Sirona XRAY Stock Holding History

Ranmore Fund Management’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.6M	Buy	+2,600,000	New	+$28.4M	3.05%	17

Other funds holding XRAY

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GHC

Great Hill Capital New York $4.29B AUM 18.17% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Continental Advisors Park City, Utah $237M AUM 21.65% 1-Year Est. Return

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

Fiduciary Alliance Greenville, South Carolina $1.48B AUM 24.99% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Ranmore Fund Management's XRAY Position: Q2 2026 in Review

Ranmore Fund Management opened a new position in Dentsply Sirona (XRAY) in Q2 2026: 2,600,000 shares worth $27.6M. The stake represents 3.05% of the portfolio and ranks #17 among its holdings.

100 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

Ranmore Fund Management held 2,600,000 shares of Dentsply Sirona worth $27.6M as of Q2 2026.
Dentsply Sirona was a new Ranmore Fund Management position in Q2 2026.
Dentsply Sirona made up 3.05% of Ranmore Fund Management's portfolio in Q2 2026, its #17 holding.
100 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Ranmore Fund Management's 13F filing for Q2 2026, filed 31 Jul 2026.